Cabal HerreraAMMandleQVarmaH, et al. Nausea and vomiting as initial manifestations of pediatric NMOSD. Pediatrics2024; 153(4): e2023062269.
2.
LiXZhangJZhangS, et al. Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends. Neural Regen Res2024; 19(12): 2735–2749.
3.
ChienCCruzESilvaVGeiterE, et al. Aquaporin-4 immunoglobulin g-seropositive neuromyelitis optica spectrum disorder MRI characteristics: data analysis from the international real-world PAMRINO study cohort. Radiology2024; 313(2): e233099.
4.
ZhangYXCaiMTHeMX, et al. Case report: neuromyelitis optica spectrum disorder with progressive elevation of cerebrospinal fluid cell count and protein level mimicking infectious meningomyelitis: a diagnostic challenge. Front Immunol2022; 13: 864664. https://doi.org/10.3389/fimmu.2022.864664
5.
DaiMHuangCZhouM, et al. Dual BLyS/APRIL targeted therapy with telitacicept in rituximab-refractory SLE-associated neuromyelitis optica spectrum disorder: a case report. Front Immunol2025; 16: 1602800.